Linzess 290μg Capsules Package Insert

Linaclotide capsules are a medication used to treat adults with constipation-predominant irritable bowel syndrome.


Linzess 290μg Capsules Package Insert - cover page
Brand
Linzess
Category
Other
Document type
Other
Language
Chinese
Pages
8
File format
PDF
File size
833 KB
Published
18 November, 2023
Updated
18 November, 2023
MD5 checksum
2EB80038FBFD79507B8D20A506E64AC1

About this manual

This document is the package insert for Linzess (Linaclotide) capsules, a prescription medication indicated for the treatment of adult constipation-predominant irritable bowel syndrome (IBS-C). The active ingredient is Linaclotide, supplied in 290μg capsules. The recommended dosage for adults is one capsule daily, taken at least 30 minutes before the first meal of the day.

The insert details the pharmacological properties, clinical trial results, and safety profile of the drug. Common adverse reactions include diarrhea, abdominal pain, and bloating. It contains specific warnings regarding the use of the drug in pediatric patients (under 6 years old) and elderly patients, as well as information on drug interactions and contraindications. This manual is written in Chinese.

What's inside

  • 药品名称
  • 成份
  • 适应症
  • 用法用量
  • 不良反应
  • 禁忌
  • 注意事项
  • 临床试验

Specifications

Active IngredientLinaclotide
Dosage FormCapsules
Strength290μg
IndicationAdult constipation-predominant irritable bowel syndrome (IBS-C)
Recommended DosageOne capsule daily, at least 30 minutes before the first meal

Frequently asked questions

Can children take Linzess?

No. Linzess is contraindicated in children under 6 years of age, and its use is not recommended for children aged 6 to 18 years due to safety and efficacy concerns.

When should Linzess be taken?

Adults should take one capsule daily at least 30 minutes before the first meal of the day.

Download PDF (833 KB)